Dividend Coverage: The $0.38 mark is well within reach for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Dividend Coverage: The $0.38 mark is well within reach for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is expected to pay $0.38 on Dec 12, 2016. The indicated annual dividend is $1.50. Shareholders owning the stock before Nov 15, 2016 will be eligible to receive the payout. Based on Walgreens Boots Alliance, Inc.’s current price of $81.05, the dividend is 0.46%. This dividend’s record date is Nov 17, 2016 and the announcement date is Oct 12, 2016. The stock increased 0.22% or $0.18 on November 11, hitting $81.05. Walgreens Boots Alliance Inc (NASDAQ:WBA) has declined 0.32% since April 12, 2016 and is downtrending. It has underperformed by 5.30% the S&P500.

Walgreens Boots Alliance, Inc. is a holding company. The company has a market cap of $87.27 billion. The Firm is a pharmacy-led health and wellbeing company. It has a 21.2 P/E ratio. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.

Walgreens Boots Alliance Inc (NASDAQ:WBA) Ratings Coverage

Out of 11 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 9 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 82% are positive. Walgreens Boots Alliance has been the topic of 20 analyst reports since August 24, 2015 according to StockzIntelligence Inc. The firm earned “Buy” rating on Wednesday, October 28 by RBC Capital Markets. As per Tuesday, September 1, the company rating was upgraded by Zacks. The firm has “Buy” rating by Zacks given on Monday, August 24. Deutsche Bank maintained Walgreens Boots Alliance Inc (NASDAQ:WBA) rating on Tuesday, August 30. Deutsche Bank has “Buy” rating and $94 price target. On Thursday, March 10 the stock rating was reinitiated by Barclays Capital with “Equal-Weight”. The stock of Walgreens Boots Alliance Inc (NASDAQ:WBA) has “Outperform” rating given on Wednesday, September 9 by Cowen & Co. Jefferies upgraded the stock to “Buy” rating in Monday, October 17 report. The stock of Walgreens Boots Alliance Inc (NASDAQ:WBA) earned “Outperform” rating by Credit Suisse on Monday, November 16. On Monday, October 31 the stock rating was initiated by Wells Fargo with “Outperform”. As per Thursday, September 1, the company rating was maintained by Credit Suisse.

More recent Walgreens Boots Alliance Inc (NASDAQ:WBA) news were published by: Forbes.com which released: “Ex-Dividend Reminder: Wynn Resorts, Walgreens Boots Alliance and Starbucks” on November 11, 2016. Also Investorplace.com published the news titled: “Walgreens Boots Alliance Inc (WBA) Sues Theranos for $140 Million” on November 09, 2016. Etfdailynews.com‘s news article titled: “Walgreens Boots Alliance Inc Posts Mixed Q4 Results, Guides In-Line” with publication date: October 20, 2016 was also an interesting one.

WBA Company Profile

Walgreens Boots Alliance, Inc., incorporated on September 2, 2014, is a holding company. The Firm is a pharmacy-led health and wellbeing company. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The Company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment